Industry Insights

Deep dives on clinical endpoints, regulatory trends and data quality — written and curated by the EClinCloud team.

Policy Interpretation | CDE Issues Rare Disease Clinical Trial Guidance Focusing on Decentralization (archive article cover)Insight4 min readPolicy Explainer | CDE Issues Rare Disease Clinical Trial Guidance Focusing on DecentralizationAt the end of May, CDE issued the "Technical Guidance on the Application of Decentralized Clinical Trials in Clinical Development of Rare Disease Drugs" (hereinafter referred to as the "Guidance"), explicitly deepening the new "patient-centric" clinical trial concept to support the clinical development of rare disease drugs.Expert Consensus | Clinical Application and Recommendations of ePRO in Oncology Nutrition (Archived Article Cover)Insight4 min readExpert Consensus | Clinical Applications and Recommendations for ePRO in Oncology NutritionToday we are sharing an expert consensus published in the first half of the year—"Expert Consensus on the Clinical Application of Patient-Reported Outcome-Based Oncology Nutrition Therapy Systems" (2024 Edition)—which notes that electronic patient-reported outcome (ePRO) systems can be applied to nutrition screening, monitoring, and management to improve intervention efficiency, reduce the burden on healthcare staff, and encourage patient engagement in nutrition interventions.Hand tremors like after drinking coffee: Could it mean a risk of Parkinson's disease like Zhang Zetian? Archive article coverInsight4 min readHand Tremors After Coffee: Could You Be at Risk for Parkinson's Disease Like Zhang Zetian?Recently, Zhang Zetian attended the 2024 Breakthrough Prize Ceremony and trended online after revealing her family history: "My family also has a Parkinson's gene. When I consume too much caffeine or don't get enough sleep, my thumb already starts to tremble a bit."Cover image for archived article: CDE's step-by-step guide to conducting patient-centric clinical researchInsight6 min readCDE's Step-by-Step Guide to Conducting Patient-Centered Clinical ResearchOn August 9, the CDE issued 3 draft guidelines for comment in succession: "Technical Guidelines for Patient-Centered Clinical Trial Implementation (Draft for Comment)," "Technical Guidelines for Patient-Centered Clinical Trial Design (Draft for Comment)," and "Technical Guidelines for Patient-Centered Clinical Trial Benefit-Risk Assessment (Draft for Comment)." "Patient-centered" drug development—taking patient needs as the starting point, viewing patients as active participants, and aiming for clinical value as the ultimate goal—has become the core guiding philosophy in current drug development."Expert Consensus on Decentralized Clinical Trials" Officially Released! Archived Article CoverInsight6 min read"Expert Consensus on Decentralized Clinical Trials" Officially ReleasedOn July 17, the launch event for EClinCloud's integrated clinical trial cloud platform was successfully held in Shanghai, featuring an engaging roundtable discussion. Moderated by Tom Tang, Senior Vice President at Adlai Nortye, the panel brought together Shen Yifeng, Director of the Clinical Trial Institution Office at Shanghai Mental Health Center; Lyu Cheng, Vice President of Translational Development and Clinical Operations at LianBio; Yu Dongsheng, General Manager at Galaxy Asset Management; and Zhang Hai, Senior Vice President of Clinical Services at Pharmaron Clinical, who shared their perspectives from clinical medicine, innovative biopharma companies, capital markets, and CROs on the progress, applications, and outlook of digitalization in pharmaceutical R&D.